We report the use of raloxifene as an adjunctive treatment, with risperidone, in treatment-resistant
form of schizophrenia. The patient, a 29-year-old woman, over a 7-month follow-up period, showed significant improvement in
socio-occupational functioning, with reduction in symptom severity.


Content Type Journal ArticleCategory Case reportPages 1-2DOI 10.1007/s00737-012-0259-1Authors
Eesha Sharma, The Metabolic Clinic in Psychiatry, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Hosur Road, Bangalore, 560029 IndiaDhanya Raveendranathan, The Metabolic Clinic in Psychiatry, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Hosur Road, Bangalore, 560029 IndiaVenkataram Shivakumar, The Metabolic Clinic in Psychiatry, Dep...

More...